Events Speakers Talks
 

Speakers

Sort by
Newest
Trending
1-14 of 14
1-14 of 14
Filter
Jarret Patton
CEO at Doctor Jarret PLLC
addiction, alternative medicine, anthony fauci, board certification, cancer, cannabidiol, cannabinoid, cannabis (drug), cigar, doctor of medicine, drug, electronic cigarette, emergency department, emotional intelligence, gateway drug effect, hospital, marihuana tax act of 1937, medical cannabis, medical school, medication, medicine, mind, national institute on drug abuse, opioid, opioid epidemic, organ transplantation, osteopathic medicine in the united states, pain, patient, pediatrics, physician, psychology, purdue pharma, reason, recreational drug use, red state (2011 film), residency (medicine), social stigma, substance abuse, tetrahydrocannabinol, tobacco, united states congress, walter o'brien
Michael Chang
Medical Director at Nutex Health
arthritis, bioavailability, brand, budtender, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, carbamazepine, chemistry, consumer protection, cytochrome p450, dietary supplement, dose (biochemistry), dream, drug development, effects of cannabis, emergency department, emulsion, endocannabinoid system, fibromyalgia, food and drug administration, gpr55, health, homeostasis, human, hydroxychloroquine, ibuprofen, medical school, medicine, memory, morphine, omega-3 fatty acid, omega-6 fatty acid, opiate, paracetamol, petroleum, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, placebo, psilocybin mushroom, randomized controlled trial, rapid eye movement sleep, route of administration, shelf life, sleep, solution, sports medicine, tablet (pharmacy), tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, transparency and translucency, vaporizer (inhalation device)
Joseph Rosado
Physician and Medical Director at International Medical Consultants and Cannabidiol Life
adalimumab, alzheimer's disease, analgesic, anticoagulant, antipsychotic, arthritis, autoimmune disease, benzodiazepine, bioavailability, bipolar disorder, bleeding, brand, budtender, cancer, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), cannabis indica, cannabis industry, cannabis sativa, cannabis strain, certificate of analysis, depression (mood), dispensary, dopamine, dose (biochemistry), dravet syndrome, drug overdose, edema, education, effects of cannabis, emergency department, emergency medical technician, endocannabinoid system, epilepsy, fibromyalgia, food and drug administration, free market, good manufacturing practice, gpr55, hair loss, hiv, homeostasis, hydroxychloroquine, hypertension, indication (medicine), insomnia, irritable bowel syndrome, lupus, medical cannabis, medical prescription, medical school, medicine, mental disorder, mental health, methotrexate, morphine, norepinephrine, omega-6 fatty acid, opiate, opioid, oxycodone, oxycodone/paracetamol, pain management, paracetamol, paramedic, parkinson's disease, pediatrics, peripheral neuropathy, pharmaceutical industry, pharmacology, physician, placebo, placebo-controlled study, post-traumatic stress disorder, prescription drug, psilocybin mushroom, psychological trauma, randomized controlled trial, rhabdomyosarcoma, rheumatoid arthritis, schizophrenia, serotonin, spasticities, sports medicine, syndrome, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, therapeutic index, tony montana, topical medication, transgenerational trauma, vaporizer (inhalation device), warfarin
Jeff Konin
Clinical Professor at College of Nursing & Health Sciences at Florida International University
arthritis, bioavailability, brand, budtender, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, carbamazepine, chemistry, consumer protection, cytochrome p450, dietary supplement, dose (biochemistry), dream, drug development, effects of cannabis, emergency department, emulsion, endocannabinoid system, fibromyalgia, food and drug administration, gpr55, health, homeostasis, human, hydroxychloroquine, ibuprofen, medical school, medicine, memory, morphine, omega-3 fatty acid, omega-6 fatty acid, opiate, paracetamol, petroleum, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, placebo, psilocybin mushroom, randomized controlled trial, rapid eye movement sleep, route of administration, shelf life, sleep, solution, sports medicine, tablet (pharmacy), tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, transparency and translucency, vaporizer (inhalation device)
Kevin Carrillo
Chief Operating Officer at Cannabinoid Nation
advertising, arthritis, audience measurement, blog, brand, brand awareness, budtender, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), cannabis edible, chocolate, coca-cola, contract, dietary supplement, digital marketing, effects of cannabis, emergency department, endocannabinoid system, facebook, fibromyalgia, food, food science, game balance, google, google search, gpr55, hashtag, homeostasis, hot chocolate, hydroxychloroquine, instagram, internet, linkedin, liquid, medical school, medicine, minimum viable product, money, morphine, news, newspaper, opiate, pay to play, pepsi, placebo, product sample, psilocybin mushroom, randomized controlled trial, research, search engine optimization, shelf life, small business, social media, social media marketing, sports medicine, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, twitter, vaporizer (inhalation device), whole foods market, yeast, youtube
Sherry Yafai, MD
Emergency Medicine Physician at The RELEAF Institute
addiction, arthritis, attention deficit hyperactivity disorder, cannabis, cannabis (drug), cannabis sativa, dose (biochemistry), electronic cigarette, emergency department, emergency medicine, heroin, ibuprofen, naproxen, off-label use, opioid, opioid use disorder, over-the-counter drug, pain management, paracetamol, physician, psychoactive drug, residency (medicine), substance dependence, uc san diego school of medicine, world wide web
Jose Belen
Founder & President at Mission Zero
cannabidiol, cannabinoid, cannabis (drug), cannabis cultivation, concealed carry, domestic pig, dose (biochemistry), emergency department, equine-assisted therapy, firefighter, herbal medicine, hydroponics, invasion, iraq, marjory stoneman douglas, medical cannabis, posttraumatic stress disorder, preventive healthcare, shell shock, southern united states, suicide, the united states air force, united states army, veteran, zolpidem
Tangy Green
CEO at Jayn Green
cannabidiol, cannabinoid, cannabis (drug), cannabis cultivation, concealed carry, domestic pig, dose (biochemistry), emergency department, equine-assisted therapy, firefighter, herbal medicine, hydroponics, invasion, iraq, marjory stoneman douglas, medical cannabis, posttraumatic stress disorder, preventive healthcare, shell shock, southern united states, suicide, the united states air force, united states army, veteran, zolpidem
Joshua Littrell
CEO/Founder at Veterans for Cannabis
cannabidiol, cannabinoid, cannabis (drug), cannabis cultivation, concealed carry, domestic pig, dose (biochemistry), emergency department, equine-assisted therapy, firefighter, herbal medicine, hydroponics, invasion, iraq, marjory stoneman douglas, medical cannabis, posttraumatic stress disorder, preventive healthcare, shell shock, southern united states, suicide, the united states air force, united states army, veteran, zolpidem
Holly Ford
Founder at President of International Business Brokerage
adalimumab, advertising, angel investor, animal testing, apple inc., arthritis, autoimmunity, bank, best practice, big-box store, brand, buyer (fashion), cancer, cannabidiol, cannabinoid, cannabis, cannabis (drug), cannabis cultivation, clinical trial, concealed carry, cvs pharmacy, digital marketing, dividend, dividend tax, dog, domestic pig, dose (biochemistry), emergency department, epilepsy, equine-assisted therapy, expense, feeling, fire safety, firefighter, flow-through entity, food, franchising, grocery store, herbal medicine, hydroponics, interest, internal revenue service, invasion, inventory, investment, iraq, kroger, limited liability company, limited liability partnership, loan, marjory stoneman douglas, market (economics), medical cannabis, medication, memory, mergers and acquisitions, mergers, and acquisitions, pain, partnership, pet, pharmacy, planogram, posttraumatic stress disorder, prescription drug, preventive healthcare, purchasing, rate of return, regulatory compliance, retail, rheumatoid arthritis, seed money, shell shock, shopify, siri, southern united states, suicide, supply chain, tax, tax rate, terpene, tetrahydrocannabinol, the united states air force, topical medication, united states army, vaccination, valuation (finance), value proposition, veteran, veterinarian, walmart, zolpidem
Lev Aminov
Director of Formulations at Hemp Farms (Plant Pharma LLC)
blood sugar level, cannabidiol, cannabis (drug), carbohydrate, clinical trial, dietary supplement, disease, dose (biochemistry), drug overdose, emergency department, food, heroin, medical cannabis, medication, neurology, neurosurgery, nicotine, opioid overdose, pharmaceutical industry, pharmacokinetics, surgery, tetrahydrocannabinol, therapy
Adam Abodeely
Board Certified Surgeon & CEO-Founder at ReserveMD
adoption, allosteric modulator, alternative medicine, anesthesia, anticoagulant, antihypertensive drug, appetite, audit, background check, bank, benzodiazepine, best practice, bioavailability, bleeding, bloating, blood sugar level, board certification, brand, breathing, budtender, c-reactive protein, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis sativa, carbohydrate, central processing unit, charlotte's web (cannabis), chemotherapy, chemotherapy-induced nausea and vomiting, clinical trial, commerce clause, controlled substances act, craft brewery and microbrewery, crohn's disease, dementia, depression (mood), diarrhea, dietary supplement, disease, dose (biochemistry), drug, drug development, drug overdose, due diligence, edema, emergency department, endocannabinoid system, entourage effect, fda food safety modernization act, fda warning letter, fibromyalgia, flavonoid, food, food and drug administration, food safety, foodborne illness, gastrointestinal disease, gastroparesis, general surgery, good manufacturing practice, gut–brain axis, headache, heartburn, hemp, hemp oil, heroin, homeostasis, ibuprofen, ileostomy, immune system, indication (medicine), inflammation, inflammatory bowel disease, inhaler, intestinal permeability, iso 9000, lemon, lobbying, lung volumes, macrophage, medical cannabis, medical prescription, medication, mind, morphine, nanotechnology, nausea, neurology, neuron, neurosurgery, neurotransmitter, nicotine, nsf international, nutraceutical, opiate, opioid, opioid epidemic in the united states, opioid overdose, over-the-counter drug, oxycodone, oxycodone/paracetamol, pain, pain management, pathology, patient, personalized medicine, pharmaceutical industry, pharmacogenomics, pharmacokinetics, pharmacology, pharmacy, physician, placebo, placebo-controlled study, polypharmacy, prescription drug, psychoactive drug, quality management system, reason, regulatory compliance, rhabdomyosarcoma, risk, route of administration, safety, scientific method, sensitivity and specificity, serotonin, serotonin syndrome, signal transduction, spasticities, stress (biology), surgery, synthetic cannabinoids, terminal illness, terpene, tetrahydrocannabinol, tetrahydrocannabinol acid, therapeutic index, therapy, toxicity, ulcerative colitis, understanding, verification and validation, warfarin, water
Luis Enrique Weyback
Founder and President at Doctor Jane
absorption (pharmacology), allergy, alzheimer's disease, bioavailability, blood sugar level, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabis, cannabis (drug), carbohydrate, chronic stress, chronic traumatic encephalopathy, clinical trial, concussion, cortisol, cortisone, crohn's disease, cytokine, dietary supplement, disease, doping in sport, dose (biochemistry), drug overdose, emergency department, fluid replacement, food, food allergy, gastrointestinal tract, grapefruit–drug interactions, healing, heart, herbal medicine, heroin, hypertension, ibuprofen, inflammation, medical cannabis, medication, medicine, naproxen, neurology, neurosurgery, nicotine, nonsteroidal anti-inflammatory drug, opioid, opioid overdose, pain, pharmaceutical industry, pharmacokinetics, reactive oxygen species, route of administration, stress (biology), surgery, tetrahydrocannabinol, therapy, trpv1, tumor necrosis factor-alpha, vasodilation, wound
Emek Blair
Founder and Chief Scientist at Puffin Hemp
absorption (pharmacology), bioavailability, blood sugar level, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabis, cannabis (drug), carbohydrate, chemist, clinical trial, concussion, cytochrome p450, dietary supplement, disease, dose (biochemistry), drug overdose, emergency department, emotion, enzyme, food, hash oil, heroin, liposome, medical cannabis, medication, memory, micelle, milk, nanotechnology, neuroimaging, neurology, neurosurgery, nicotine, opioid overdose, pharmaceutical industry, pharmacokinetics, receptor (biochemistry), receptor antagonist, surfactant, surgery, tetrahydrocannabinol, therapy
1
1-14 of 14